Kurzhals, J.K.; Klee, G.; Hagelstein, V.; Zillikens, D.; Terheyden, P.; Langan, E.A.
Disease Recurrence during Adjuvant Immune Checkpoint Inhibitor Treatment in Metastatic Melanoma: Clinical, Laboratory, and Radiological Characteristics in Patients from a Single Tertiary Referral Center. Int. J. Mol. Sci. 2022, 23, 10723.
https://doi.org/10.3390/ijms231810723
AMA Style
Kurzhals JK, Klee G, Hagelstein V, Zillikens D, Terheyden P, Langan EA.
Disease Recurrence during Adjuvant Immune Checkpoint Inhibitor Treatment in Metastatic Melanoma: Clinical, Laboratory, and Radiological Characteristics in Patients from a Single Tertiary Referral Center. International Journal of Molecular Sciences. 2022; 23(18):10723.
https://doi.org/10.3390/ijms231810723
Chicago/Turabian Style
Kurzhals, Jonas K., Gina Klee, Victoria Hagelstein, Detlef Zillikens, Patrick Terheyden, and Ewan A. Langan.
2022. "Disease Recurrence during Adjuvant Immune Checkpoint Inhibitor Treatment in Metastatic Melanoma: Clinical, Laboratory, and Radiological Characteristics in Patients from a Single Tertiary Referral Center" International Journal of Molecular Sciences 23, no. 18: 10723.
https://doi.org/10.3390/ijms231810723
APA Style
Kurzhals, J. K., Klee, G., Hagelstein, V., Zillikens, D., Terheyden, P., & Langan, E. A.
(2022). Disease Recurrence during Adjuvant Immune Checkpoint Inhibitor Treatment in Metastatic Melanoma: Clinical, Laboratory, and Radiological Characteristics in Patients from a Single Tertiary Referral Center. International Journal of Molecular Sciences, 23(18), 10723.
https://doi.org/10.3390/ijms231810723
